Data / Form D filings / Spry Therapeutics Inc.
Spry Therapeutics Inc.: Form D filing
Spry Therapeutics Inc., a health care company in Mumbai, Maharashtra, India, filed a Form D with the SEC in 2024. The latest, on November 19, 2024, reports $15 million sold of a $15 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 18 SANGAM B WING, FOUR BUNGLOWS, HARIDWAR MARG, NORTH MUMBAI SUBURBAN, Mumbai, Maharashtra, India, 40006
- Phone
- (982) 057-8114
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2044487
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | New notice | $14,999,996 | $14,999,996 | 4 | Oct 3, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gupta Venkatachalam Shubham | Director | |
| Prem Venkatachalam Pavoor | Director | |
| Carl Venkatachalam Byers | Director |
Every Form D from the week of Nov 18, 2024 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Spry Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.